Piotr Budnik, MBBCh FCP(SA)

Senior Medical Affairs Director
ViiV Healthcare
London, England, United Kingdom

Disclosure(s): GSK: Stocks/Bonds (Public Company); ViiV Healthcare: Employee

Presentation(s):

• 508 - Cabotegravir Long-Acting for Pre-Exposure Prophylaxis (PrEP): Real World Data on On-Time Dosing, HIV Testing and HIV Acquisition from the OPERA Cohort

  Saturday, October 19, 2024
  11:30 AM – 11:45 AM US PT